Quoin Pharmaceuticals Ltd (QNRX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Quoin Pharmaceuticals Ltd   (NASDAQ: QNRX)


Quoin Pharmaceuticals Ltd's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Quoin Pharmaceuticals Ltd's ROI in the second quarter of 2026?
Quoin Pharmaceuticals Ltd recorded a cumulative net loss of $-19 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -239.25%.

Within the Healthcare sector 755 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3885 to 4275.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -2.84 % -19.18 % -32.01 % -35.43 % -21.81 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 5 10 15 1 5
Return On Investment (TTM) -239.25 % -223.37 % -224.36 % -221.5 % -151.55 %
QNRX's Overall Ranking # 4275 # 3885 # 3697 # 3946 # 2487
Seq. Investment Change TTM 2.57 % 7.98 % 13.33 % -22.59 % -14.68 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -19 -17 -16 -14 -12

QNRX Company Profile >> Back to QNRX Roi Comparisons >> See Annual QNRX Return On Investment



Return On Investment QNRX's Ranking
Within: No.
Industry # 362
Sector # 756
Overall # 4275

Return On Investment Statistics
High Average Low
239.85 %
-109.93 %
-1075.76 %
(Dec 31 2020)   (Sep 30 2022)



  News about Quoin Pharmaceuticals Ltd Return on Investment ROI

Quoin Pharmaceuticals' Public Offering Raises Concerns as Company Records Negative ROI and Trails Behind Industry Peers in Financial Performance.

March 5, 2024

Quoin Pharmaceuticals Public Offering Raises Concerns about Company s Financial Health
ASHBURN, Va., March 05, 2024 - Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) announced the pricing of its public offering, raising approximately $6.5 million in gross proceeds. However, the financial performance of the specialty pharmaceutical company raises concerns about its long-term viability.
Quoin Pharmaceuticals, focused on rare and orphan diseases, faces significant challenges as it recorded a cumulative net loss of $-16 million in the 12 months ending in the third quarter of 2023. This resulted in a negative return on investment (ROI) of -134.02%, which is alarming. Furthermore, within the healthcare sector, 823 other companies demonstrated a higher return on investment, indicating Quoin s underperformance compared to its peers.





Financial Statements
Quoin Pharmaceuticals Ltd's II. Quarter Investments $ 5 Millions QNRX's Balance sheet
Quoin Pharmaceuticals Ltd's II. Quarter Income $ -5 Millions Quarterly QNRX's Income Statement
QNRX's Income by Division See QNRX's Income by Division


QNRX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 15 12 9 11 5
Y / Y Investment Growth 28.76 % 34.24 % -21.43 % 128.64 % -
Net Income in Millions -16 -9 -9 -9 -21
Y / Y Net Income Growth - - - - -
Annual Return On Investment -106.44 % -78.07 % -101.31 % -85.83 % -448.94 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
QNRX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for QNRX's Competitors
Subscribers only: Roi for Quoin Pharmaceuticals Ltd's Suppliers
Subscribers only: Return On Investment for QNRX's Customers

Other Ratios
QNRX's Roa QNRX's Inventory Turnover Ratio QNRX's Growth Rates QNRX's Dividend Statistics
QNRX's Profitability Ratios QNRX's Asset Turnover Ratio QNRX's Dividend Growth
QNRX's Roe QNRX's Valuation Ratios QNRX's Financial Strength Ratios QNRX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-08-16T08:52:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.